Skip to main content

Barney Saunders

Purigen Biosystems has named Barney Saunders as its new CEO and a member of the board of directors. Saunders joins the Pleasanton, California-based nucleic acid sample prep firm from NanoString Technologies, where he served as SVP of sales and marketing, SVP and GM of life sciences, and chief commercial officer. He also previously served as chief commercial officer of Microchip Biotechnologies (which became IntegenX), and as a general manager at Agilent Technologies, where he led the team that launched the first commercially available full genome arrays for human, rat, and mouse.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.